B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CCL2

MOLECULAR TARGET

C-C motif chemokine ligand 2

UniProt: P13500NCBI Gene: 63478 compounds

CCL2 (C-C motif chemokine ligand 2) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CCL2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1fasudil3.6638
2y 276323.4731
3gsk0462.4010
4hydroxyfasudil2.4010
5gsk6202.309
6azd 51532.208
7gsk7782.087
8hydroxyfasudil [Supplementary Concept]0.691

About CCL2 as a Drug Target

CCL2 (C-C motif chemokine ligand 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented CCL2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CCL2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.